Abstract
The vaginal microbiota may be important for pregnancy prognosis because vaginal dysbiosis during pregnancy appears to be related to preterm birth (PTB) or pregnancy loss. Previous reports have indicated that a Lactobacillus-poor microbial flora in the vagina and intrauterine infection by diverse anaerobes ascending from the vagina are associated with undesirable delivery outcomes. However, no research has involved the use of pyrosequencing analysis to examine vaginal microbiota profiles or their potential associations with high-risk pregnancy in Korean women. Vaginal swabs were collected from 500 Korean women for the identification of community state types (CSTs). Of these, 137 samples were further analyzed using a Roche/454 GS Junior pyrosequencer. Three distinct CSTs were identified based on the dominant vaginal microbes: CST I (Lactobacillus crispatus dominated), CST III (Lactobacillus iners dominated), and CST IV (with diverse species of anaerobes). Twelve of the 67 pregnant women had undesirable pregnancy outcomes (four miscarriages and eight PTBs). The dominant microbe in the vaginal microbiota of women who gave birth at full-term was L. crispatus. In contrast, L. iners was the dominant vaginal microbe in women who miscarried. Most (n = 6/8) vaginal microbiota profiles of women who experienced PTB could be classified as CST IV, with diverse bacteria, including anaerobic vaginal species. The present study provides valuable information regarding the characteristics of the vaginal microbiota of Korean women related to high-risk pregnancy. Investigation of the vaginal microbiotic structure in pregnant Korean women is necessary to enable better prediction of adverse pregnancy outcomes.
Keywords: Vaginal microbiota, high risk pregnancy, preterm, miscarriage
Introduction
Since the development of pyrosequencing platform technologies, the human microbiota has received increasing attention because of its associations with aspects of human health and disease, including immune programming, protection from pathogens, and nutrient acquisition [1, 2]. In addition, the beneficial roles of the human microbiota have been investigated for application to many health issues, including obesity [3, 4], poor immune response [5], and inflammation [6]. In particular, the vaginal microbial flora reportedly plays a significant role in pregnancy, protecting the health of the mother and fetus [5, 6]. Several studies have examined the vaginal microbiota during pregnancy using culture-independent molecular techniques [7-9]. These studies have consistently shown that the vaginal microbial communities of pregnant women are dominated by Lactobacillus species and are characterized by less species richness and diversity, but greater stability, compared with those of non-pregnant women. A Lactobacillus-poor vaginal flora may disrupt the microbial balance in the vagina, often resulting in bacterial vaginosis, which is associated with high-risk pregnancy [5, 8].
Most research published to date on the human vaginal microbial ecosystem has focused on the microbiota of healthy asymptomatic women of reproductive age. The vaginal microbiota undergoes major compositional changes throughout a woman’s lifespan, from birth to puberty to menopause [10-12]. Vaginal microbial abnormality increases the risks for various obstetric and gynecological diseases and conditions, such as sexually transmitted infections [13], preterm birth (PTB) [14, 15], early and late miscarriage [16], recurrent abortion [17], histological chorioamnionitis [18] and postpartum endometritis [19]. Recently, a Lactobacillus-poor vaginal flora in the female reproductive tract was associated not only with high-risk pregnancy, but also with implantation failure, indicating the importance of the female microbiota for gynecological and obstetric health [20, 21].
The vaginal microbial composition may provide useful information for accurate and rapid diagnosis or prediction of pregnancy conditions. For example, Haque et al. insisted that vaginal microbiota enables early and highly accurate prediction of preterm delivery outcomes, and can potentially be deployed in clinical settings for preterm birth risk-assessment [22]. However, the vaginal microbiota and its association with high-risk pregnancy remain poorly understood, and in some cases, current knowledge is contradictory. Hyman et al. [14] reported that PTB was linked to greater intracommunity alpha-diversity in the vagina. DiGiulio et al. claimed that prevalence of a Lactobacillus-poor vaginal community state type (CST IV) was inversely correlated with gestational age at delivery [8]. In contrast, Romero et al. found no significant association between PTB and any specific community state type (CST) or the relative abundance of microbial phylotypes [20]. Moreover, several reports [21, 23] have indicated that the vaginal microbiota can differ based on race and ethnicity, which emphasizes the strong need for individual studies to appropriately evaluate the vaginal microbiota in various ethnic groups.
In the present study, the vaginal microbiota profiles of 137 Korean women were examined using a 454 GS Junior pyrosequencing system (Roche). The microbial community structure and representative microbial groups in normal and high-risk pregnancy groups were identified. We then analyzed correlations between community structure and delivery outcomes, such as PTB and miscarriage, to identify specific microbial taxonomic targets for prediction. This formulation could aid the prediction of possible pregnancy outcomes and prevent reproductive health complications in Korean women.
Methods
Study Population and Sampling
This study received ethical approval from Konyang University Hospital Institutional Review Board (IRB) (Approval Number 2014-06-009). All participants provided written informed consent and all methods were performed in accordance with the relevant guidelines and regulations. Women attending antenatal clinics of Department of Obstetrics and Gynecology, College of Medicine, Myunggok Medical Research Center, Konyang University (Korea) between September 2014 and August 2018 were invited to be part of a clinical trial to determine the vaginal microbiome structures of Korean women. This study was conducted as a prospective observational study. For non-pregnant women, samples were obtained as being non-menstrual. The vaginal swabs were not collected at any specific non-menstrual cycle time as previous report has demonstrated there is little variation in microbiota structures through the cycle [24]. Vaginal swabs collected from pregnant women at 16-20 weeks of gestational age were used for bacterial community analysis. Vaginal swabs were collected under direct visualization using a speculum by either a physician or a nurse and placed in dry tubes prior to being placed in −80°C. A total of 137 women were enrolled in the vaginal microbiome study, including 67 pregnant women. After pyrosequencing, 11 of the 137 metagenome samples were found to have an average low read quality (Phred quality score <20), short average read length (< 250 bp) or low sequencing output (the number of reads per sample < 500). Therefore, the 11 metagenome data (7 pregnant & 4 non-pregnant) were excluded from further analysis. For the PTB group (n = 8), eligible participants for this study were women who had undergone preterm deliveries at greater than 16 weeks but less than 37 weeks, where onset of labor occurred spontaneously or in association with cervical incompetence or preterm premature rupture of membranes (PPROM). The microbial profiles of pregnant women with term-deliveries (n = 48) were compared to profiles generated from PTB (n = 8), miscarriage (n = 4) and non-pregnant Korean women (n = 66).
PCR Amplification of 16S rRNA Genes and Pyrosequencing
Frozen vaginal swabs were sent to Chunlab, Inc. (Korea) for pyrosequencing analysis. Total nucleic acid was extracted from swabs using Mobio Soil kit (Qiagen, USA) according to the manufacturer’s instruction. PCR amplification was performed using primers targeting from V1 to V3 regions of the 16S rRNA gene with extracted DNA. For bacterial amplification, barcoded primers of 9F 5’-CCTATCCCCTGTGTGCCTTGGCAGTC-TCAG-AC-AGAGTTTGATCMTGGCTCAG-3’; underlining sequence indicates the target region primer) and 541R 5’-CCATCTCAT CCCTGCGTGTCTCCGAC-TCAG-X-AC-ATTACCGCGGCTGCTGG-3’; ‘X’ indicates the unique barcode for each subject). The amplifications were carried out under the following conditions: initial denaturation at 95°C for 5 min, followed by 30 cycles of denaturation at 95°C for 30 sec, primer annealing at 55°C for 30 sec, and extension at 72°C for 30 sec, with a final elongation at 72°C for 5 min. The PCR products were confirmed by using 2%agarose gel electrophoresis and visualized under a Gel Doc system (BioRad, USA). The amplified products were purified with the QIAquick PCR purification kit (Qiagen). Equal concentrations of purified products were pooled together and removed short fragments (non-target products) with Ampure beads kit (Agencourt Bioscience, USA). The quality and product size were assessed on a Bioanalyzer 2100 (Agilent, USA) using a DNA 7500 chip. Mixed amplicons were conducted emlusion PCR, and then deposited on Picotiter plates. The sequencing was carried out at Chunlab, Inc., with Roche/454 GS Junior Sequencing System (Roche, USA) according to the manufacturer’s instructions.
Pyrosequencing Data Analysis
The basic analysis was conducted according to the previous descriptions in other studies [25-27]. Obtained reads from the different samples were sorted by unique barcodes of each PCR product. The sequences of the barcode, linker, and primers were removed from the original sequencing reads. Any reads containing two or more ambiguous nucleotides were discarded. Potential chimera sequences were detected by the bellerophone method, which is comparing the BLASTN search results between forward half and reverse half sequences [28]. After removing chimera sequences, the taxonomic classification of each read was assigned against the EzBioClud Database (https://www.ezbiocloud.net/ ) [29], which contains 16S rRNA gene sequence of type strains that have valid published names and representative species level phylotypes of either cultured or uncultured entries in the GenBank database with complete hierarchical taxonomic classification from the phylum to the species. The richness and diversity of samples were determined by Chao1 estimation and Shannon diversity index at the 3% distance. Random subsampling was conducted to equalize read size (n = 1,108) of samples for comparing different read sizes among samples. The overall phylogenetic distance between communities was estimated using the Fast UniFrac [30] and visualized using principal coordinate analysis (PCoA). Using CLcommunity program (Chunlab Inc.,), all the rarefaction curves were obtained (Fig. S1). To compare OTUs between samples, shared OTUs were obtained with the XOR analysis of CLcommunity program.
Heatmap and Principal Coordinates Analysis (PCoA)
QIIME v1.9.1-dev software suite [31] was used to analyze the generated 454 pyrosequencing reads. Briefly, all reads were truncated to an even length (515 nt) using the QIIME script truncate_fasta_qual_files.py. After removal of low quality reads, operational taxonomic units (OTUs) were clustered using the QIIME script pick_open_reference_otus.py at 97% identity. An additional filtering process was conducted by first aligning all OTU sequences to Greengenes 13_8 Database using PYNAST version 1.2.2 [32]. OTU taxonomy was determined using Ribosomal Database Project classifier. Principle Coordinate Analysis (PCoA) was performed by calculating weighted and unweighted UniFrac distance between each pair of samples (QIIME script function beta_diversity_through_plots.py) on a normalized OTU table.
Data Availability
Raw sequence data files for the 126 samples described in this study are available in the European Nucleotide Archive under study accession PRJEB33541. Due to ethical and legal restrictions related to protecting participant privacy imposed by Konyang Medical School IRB, all other relevant data are available upon request pending ethical approval.
Results
Sample Collection and Pregnancy Outcomes
In the present study, we characterized the vaginal microbiota profiles of pregnant and non-pregnant native Korean women. We collected vaginal swabs at 16–20 weeks of gestation. The possibility of PTB or miscarriage was usually assessed during the first or second trimester, and therapeutic interventions at this gestational stage have been considered to be efficacious [33]. In addition, pregnant women in Korea first visit the hospital at this gestational age, at which time vaginal swabs are taken to screen for vaginal infection.
From September 2014 to August 2018, we collected more than 500 vaginal swabs from native Korean women (430 pregnant and 70 non-pregnant). A portion of the collected vaginal swabs (137 samples collected from September 2014 to October 2016) was sent to Chunlab, Inc. for next-generation sequencing (NGS) analysis. Initially, Chunlab, Inc. used a GS Junior sequencing system (Roche) for the metagenome analysis of 16S rRNA gene amplicons; due to the unavailability of the Roche 454 platform service, the Illumina MiSeq sequencing system (Illumina, USA) service has been used since January 2017. Therefore, our reporting on the vaginal microbiota profiles of pregnant and non-pregnant Korean women and their possible associations with undesirable delivery outcomes is based on the 137 initially collected vaginal swab samples [from 67 pregnant women (with 55 term deliveries, 8 preterm deliveries, and 4 miscarriages) and 70 non-pregnant women] analyzed using the Roche 454 NGS platform. The collection of vaginal samples is ongoing, and when the additional 30+ samples from women who experienced PTB are analyzed using the MiSeq platform, the updated results will be reported in combination with the present work. To date, 20 additional swabs from women who experienced PTB and 6 additional swabs from women who miscarried have been collected and are being analyzed using the Illumina MiSeq pyrosequencer. Currently, the total numbers of samples from women with PTB and miscarriage outcomes are 28 and 10, respectively.
Among the 137 samples submitted for NGS using the Roche 454 platform, 11 metagenome sequences (from 7 pregnant and 4 non-pregnant women) were of insufficient quality for further analyses, such as heatmap analysis and principal coordinates analysis (PCoA). Therefore, NGS data from only 126 samples [from 60 pregnant women (with 48 term births, 8 PTBs, and 4 miscarriages) and 66 non-pregnant women] were used; corresponding personal information is summarized in Table 1. The sociodemographic characteristics of 48 women who gave birth at term, 28 women who had preterm deliveries (8 samples analyzed with the Roche 454 and 20 analyzed with the Illumina MiSeq platform), and 10 women who miscarried (4 samples analyzed with the Roche 454 and 6 analyzed with the Illumina MiSeq platform) are summarized in Table 2 and in Supplemental Table 1, respectively.
Table 1.
Characteristics | Non-pregnant (n=66) | pregnant (n=60) | p value |
---|---|---|---|
Age(Mean SD,Range) | 38±1.1 (20-58) | 33.2±0.42 (26-40) | <0.0001 |
20-30 | 13 | 13 | |
31-35 | 20 | 32 | |
36-40 | 10 | 15 | |
41-50 | 16 | - | |
51-60 | 7 | - | |
Missing data | - | - | |
Height(Mean SD,Range) | 160.1±0.5 (149-174) | 162.6±0.6 (153-174) | 0.002 |
146-150 | 2 | - | |
151-155 | 8 | 3 | |
156-160 | 27 | 20 | |
161-165 | 21 | 24 | |
166-170 | 3 | 8 | |
171-175 | 2 | 2 | |
Missing data | 3 | 3 | |
Weight(Mean SD,Range) | 58.2±1.1 (51-98) | 64.4±1.4 (48.4-97) | 0.001 |
40-50 | 8 | 2 | |
51-60 | 39 | 21 | |
61-70 | 13 | 23 | |
71-80 | 2 | 7 | |
81-90 | - | 1 | |
91-100 | 1 | 3 | |
Missing data | 3 | 3 | |
BMI(Mean SD,Range) | 22.8±0.4 (15.82-38.3) | 24.2±0.5 (17.1-36.48) | 0.031 |
Underweight(<18.50) | 3 | 3 | |
Normal weight(18.51<24.9) | 48 | 30 | |
Overweight(25.0-29.9) | 9 | 20 | |
Obese (>30) | 3 | 4 | |
Missing data | 3 | 3 |
Table 2.
Characteristics | Term birth ≥37 weeks (n=48) | Preterm birth <37 week (n=28) | p value |
---|---|---|---|
Age(Mean SD,Range) | 33±05 (26-40) | 33.7±0.7 (26-41) | 0.503 |
20-30 | 11 (22.9%) | 6 (21.4%) | |
31-35 | 25 (52.1%) | 12 (42.9%) | |
36-40 | 12 (25.0%) | 9 (32.1%) | |
41-50 | - | 1 (3.6%) | |
Missing data | - | - | |
Height(Mean SD,Range) | 163.4±0.6 (153-174) | 159.5±0.7 (153-166.4) | <0.0001 |
145-150 | - | - | |
151-155 | 3 (6.3%) | 5 (17.9%) | |
156-160 | 10 (20.8%) | 15 (53.6%) | |
161-165 | 22 (45.8%) | 6 (21.4%) | |
166-170 | 8 (16.7%) | 2 (7.1%) | |
171-175 | 2 (4.2%) | - | |
Missing data | 3 (6.3%) | - | |
Weight(Mean SD,Range) | 65.1±1.7 (62-97) | 63.9±1.4 (49.8-86) | 0.615 |
40-50 | 2 (4.2%) | 1 (3.6%) | |
51-60 | 16 (33.3%) | 7 (25.0%) | |
61-70 | 16 (33.3%) | 18 (64.3%) | |
71-80 | 7 (14.6%) | 2 (7.1%) | |
81-90 | 1 (2.1%) | - | |
91-100 | 3 (6.3%) | - | |
Missing data | 3 (6.3%) | - | |
BMI(Mean SD,Range) | 24.4±0.6 (17.1-36.48) | 24.9±0.6 (19.7-31.9) | 0.543 |
Underweight(<18.50) | 3 (6.3%) | - | |
Normal weight(18.51<24.9) | 23 (47.9%) | 13 (46.4%) | |
Overweight(25.0-29.9) | 15 (31.3%) | 13 (46.4%) | |
Obese (>30) | 4 (8.3%) | 2 (7.1%) | |
Missing data | 3 (6.3%) | - | |
Delivery | 0.572 | ||
Natural | |||
childbirth | 19 (39.6%) | 11 (39.3%) | |
Cesarean | 16 (33.3%) | 17 (60.7%) | |
Missing data | 13 (27.1%) | - | |
Pregnancy | 0.902 | ||
Naturally conceived | 35 (72.9%) | 24 (85.7%) | |
Embryo transfer | 1 (2.1%) | 4 (14.3%) | |
Unknown | 12 (25.0%) | - | |
Gestational weeks at delivery | 39+1 (37+1-41+2) | 34+1 (17-36+6) | <0.0001 |
delivery of times | 0.620 | ||
0 | 10 (20.8%) | 12 (42.9%) | |
1 | 9 (18.8%) | 7 (25%) | |
>2 | 24 (50%) | 9 (32.1%) | |
missing data | 5 (10.4%) | - | |
Baby | |||
Boy | 14 | 16 | |
Girl | 21 | 15 | |
Missing data | 13 | - | |
Weight(g) | 3366±72 | 2385±144 | <0.0001 |
Weight(<2500g) | 1 | 17 |
Operational Taxonomic Unit Analysis and Microbiota Profiles
The Roche 454 NGS raw sequence data files for the 126 samples described in this study are available in the European Nucleotide Archive under study accession number PRJEB33541. In total, 1,068,077 16S rRNA gene reads were generated. The median and average read counts per sample were 4,021 and 6,698 (range, 398–42,166), respectively. The average read length was 431 bp. In total, 352 families, 235 genera, and 64 bacterial species were identified. Most (73.9%) reads were identified as Lactobacillus spp. The two most abundant OTUs, which corresponded to Lactobacillus species, accounted for 64.6%of all reads generated (33.7% Lactobacillus crispatus and 30.9% Lactobacillus iners). Additional Lactobacillus OTUs were found, accounting for 9.4% of all reads. The remainder of the vaginal microbes (non-Lactobacillus) generally belonged to strictly anaerobic bacteria (26.1%; Fig. 1). Species with the most read numbers were L. crispatus [358,089 (33.7%)], L. iners [327,884 (30.9%)], Lactobacillus jensenii [38,601 (3.6%)], and Atopobium vaginae [35,148 (3.3%)]. Species with the greatest sample prevalence were L. iners [84/126 (66.7%)], L. crispatus [82/126 (65.1%)], Lactobacillus helveticus [46/126 (36.5%)], and Ureaplasma parvum [38/126 (30.2%)]. Although reads with similarity to L. helveticus were detected in more than 36% (46/126) of samples, they were in very low abundance, representing only 0.02% of all reads. Overall, most species with the most abundant reads and greatest prevalence were of the genus Lactobacillus (Table 3).
Table 3.
Species | Prevalence/126(%) | % total reads | Reads |
---|---|---|---|
Lactobacillus sp. | 93 (73.8%) | 0.3 | 3,470 |
Lactobacillus iners | 84 (66.7%) | 30.9 | 327,884 |
Lactobacillus crispatus | 82 (65.1%) | 33.7 | 358,089 |
Lactobacillaceae | 80 (63.5%) | 0.0 | 444 |
Lactobacillus helveticus | 46 (36.5%) | 0.0 | 260 |
Lactobacillus sp. | 42 (33.3%) | 0.2 | 2,514 |
Ureaplasma parvum | 38 (30.2%) | 1.8 | 18,741 |
Atopobium vaginae | 36 (28.6%) | 3.3 | 35,148 |
Lactobacillus psittaci | 36 (28.6%) | 0.5 | 5,604 |
Lactobacillus jensenii | 35 (27.8%) | 3.6 | 38,601 |
Gardnerella vaginalis | 31 (24.6%) | 0.4 | 4,761 |
Prevotella timonensis | 31 (24.6%) | 0.7 | 7,661 |
Dialister micraerophilus | 31 (24.6%) | 0.5 | 5,368 |
Prevotella bivia | 28 (22.2%) | 1.4 | 15,402 |
Prevotella sp. | 27 (21.4%) | 0.0 | 344 |
Lactobacillus vaginalis | 26 (20.6%) | 0.0 | 356 |
Megasphaera sp. | 24 (19.0%) | 2.0 | 20,893 |
Lactobacillus kitasatonis | 24 (19.0%) | 0.0 | 85 |
Lactobacillus ultunensis | 23 (18.3%) | 0.0 | 85 |
Veillonellaceae | 22 (17.5%) | 0.0 | 72 |
Dialister sp. | 21 (16.7%) | 0.2 | 2,311 |
Aerococcus christensenii | 21 (16.7%) | 0.1 | 1,053 |
Prevotellaceae | 21 (16.7%) | 0.0 | 154 |
Atopobium sp. | 21 (16.7%) | 0.0 | 72 |
Megasphaera sp. | 20 (15.9%) | 0.0 | 133 |
Lactobacillus gasseri | 18 (14.3%) | 2.2 | 23,384 |
Peptoniphilus indolicus | 18 (14.3%) | 0.0 | 326 |
Sneathia sanguinegens | 17 (13.5%) | 0.7 | 7,535 |
Coriobacteriaceae | 17 (13.5%) | 0.2 | 1,745 |
Microbacterium laevaniformans group | 17 (13.5%) | 0.1 | 705 |
Leptotrichia amnionii | 16 (12.7%) | 2.8 | 29,310 |
Lactobacillus rodentium | 16 (12.7%) | 0.0 | 254 |
Lactobacillus sp. | 16 (12.7%) | 0.0 | 61 |
Lactobacillales | 16 (12.7%) | 0.0 | 20 |
Streptococcus anginosus | 15 (11.9%) | 1.1 | 12,176 |
Dialister sp. | 15 (11.9%) | 0.0 | 48 |
Gordonia sputi group | 14 (11.1%) | 0.4 | 4,004 |
Lactobacillus sp. | 14 (11.1%) | 0.1 | 649 |
Propionibacterium acnes | 14 (11.1%) | 0.0 | 50 |
Ruminococcaceae | 13 (10.3%) | 0.2 | 1,672 |
Prevotella sp. | 13 (10.3%) | 0.0 | 480 |
Dialister propionicifaciens | 13 (10.3%) | 0.0 | 73 |
The Remainder species | 12.7 | 136,080 |
Abundance of Lactobacillus spp.
The proportion of reads from Lactobacillus spp. in all 126 vaginal samples was 73.9% (785,508/1,062,319; Fig. 1A). The microbiota profiles of pregnant women (including women in the PTB and miscarriage groups) were compared with those of non-pregnant women. In the pregnant cohort, the proportion of L. crispatus (39.9%) was larger than that of L. iners (28.1%). In addition, the proportion of the non-Lactobacillus spp. was smaller in pregnant women (23.5%) than in non-pregnant women (28.4%; Figs. 1B and 1C). In particular, the proportion of L. crispatus from women with term deliveries (45.5%) was much larger than the proportions from pregnant (39.9%) and non-pregnant (28.1%) women (Fig. 1D). In contrast, the proportion of non-Lactobacillus spp. was 74.6% for women with preterm deliveries (Fig. 1E). Interestingly, L. iners was the most abundant bacterial species in the miscarriage group (Fig. 1F). Similar to previous studies, the proportion of Lactobacillus spp. from vaginal swabs followed a bimodal distribution in the present study (Fig. S2). The microbiota of most non-pregnant women had low (0–20%; n = 19/66) or high (80–100%; n = 43/66) abundances of Lactobacillus spp.; only 4/66 (6.1%) swabs exhibited intermediate (20–80%) levels. For pregnant women with term deliveries, 10/ 48 swabs had low (0–20%) and 34/48 swabs had high (80–100%) abundances of Lactobacillus spp. Only 4/48 (8.3%) swabs had intermediate (20–80%) levels. No such bimodal distribution was observed for the PTB or miscarriage group. Most [6/8 (75%)] swabs from the PTB group had low (0–20%) abundances, and all [4/4 (100%)] swabs from the miscarriage group had high (80–100%) abundances of Lactobacillus spp. (Fig. S2).
Community State Type Analysis
Ravel and Gajer [34] previously clustered vaginal microbial communities into five groups: four were dominated by Lactobacillus crispatus (CST I), L. gasseri (CST II), L. iners (CST III), or L. jensenii (CST V), whereas the fifth had lower proportions of lactic acid bacteria and higher proportions of strictly anaerobic organisms (CST IV). In the present study, hierarchical clustering of vaginal microbiota profiles from native Korean pregnant and non-pregnant women resulted in the resolution of three clearly distinct CSTs (Fig. 2). Only two Lactobacillus-dominated CSTs [CST I and CST III], based on pyrosequencing of the 16 S rRNA gene, were detected frequently. Most (84/126) profiles were dominated by one of two Lactobacillus species among three CSTs: CST I (L. crispatus; n = 45), CST III (L. iners; n = 33) and CST I + III (an approximately equal mixture of L. crispatus and L. iners; n = 6). All (n = 42) non-Lactobacillus–dominated samples were assigned to CST IV, the most heterogeneous group, which included mixtures of genera such as Atopobium and Gardnerella and combinations of Prevotella, Sneathia, Megasphaera, Streptococcus, Dialister, and Ureaplasma.
The CSTs of pregnant women in the term delivery group were compared with those in the non-pregnant group. In the latter group, 26/66 (39.4%) samples were assigned to CST IV, with the remainder assigned to the Lactobacillus-dominated CST I [20/66 (30.3%)] and CST II I [20/66 (30.3%)]. In the pregnant group with term deliveries, 34/48 samples were assigned to CST I [24/48 (50.0%)] and CST III [10/48 (20.8%)], with the remainder [14/48 (29.2%)] assigned to the non-Lactobacillus–dominated CST IV. In the PCoA ordination, the overall microbial CST could not be differentiated based on pregnancy status (Fig. 3A). Most [6/8 (75%)] samples from the PTB group were assigned to CST IV, with the remainder assigned to CST I [1/8 (12.5%)] and CST III [1/8 (12.5%)]. In contrast, most [3/4 (75%)] samples from the miscarriage group were assigned to CST III, with the remainder [1/4 (25%)] assigned to CST IV.
Alpha Diversity Analysis
The assessment of alpha diversity revealed that the microbiomes of pregnant women with term deliveries (n = 48) were slightly less diverse (Shannon diversity index, 2.2± 0.1) and less rich (Chao1, 85.1 ± 9.8) compared with those of non-pregnant women (2.7 ± 0.1 and 134 ± 24.3, respectively; Fig. S3).
Prevalence and Abundance of Ureaplasma parvum
Ureaplasma spp. are Gram negative bacteria which frequently colonize the genitourinary tract [35]. There is supporting evidence that Ureaplasma spp. may act as low grade pathogens in pregnancy [36]. Recently, Cox et al. reported that the common vaginal commensal bacterium Ureaplasma parvum is associated with chorioamnionitis in extreme preterm labor [37]. Roche 454 pyrosequencing detected reads of Mollicutes (Ureaplasma and/or Mycoplasma) in 30/66 (45.5%) samples from non-pregnant women, 25/60 (41.7%) samples from pregnant women in the term delivery group, 3/8 (37.5%) samples from women with preterm deliveries, and 1/4 (25%) samples from women who miscarried, but the prevalence varied among CSTs: 28.9%, 48.5%, and 19.0% in CSTs I, III, and IV, respectively. U. parvum was detected in samples from 18/ 66 (27.3%) non-pregnant women, 16/48 (33.3%) pregnant women with term deliveries, 3/8 (37.5%) women with preterm deliveries, and 1/4 (25%) women who miscarried. The prevalence of U. parvum did not vary significantly according to pregnancy status or delivery outcome. However, U. parvum was much less abundant in vaginal swabs from pregnant women in the term delivery group (0.08%) than in those from the non-pregnant (3.13%), PTB (0.93%), and miscarriage (1.71%) groups.
Discussion
The NGS data for the vaginal microbiota profiles of 126 Korean women are summarized in Fig. 1. The microbial profiles from pregnant women clustered into three CSTs (I, III, and IV, originally defined by Ravel and Gajer [34]); CST II (L. jensenii dominant) and CST V (L. gasseri dominant) were not detected in the 126 samples analyzed by Roche 454 sequencing in this study (Fig. 2). Among the pregnant women, 48/60 (80.0%) delivered at >36+6 gestational weeks (mean, 39+1 weeks), and 8/60 (13.3%) delivered at <37+0 gestational weeks (mean, 34+1 weeks). The remaining four (6.7%) women miscarried at gestational ages > 18 weeks. The mean birth weights of newborns in the term delivery and PTB groups were 3,366 ± 72 and 2,260 ± 140 g, respectively. Based on the major vaginal microbial taxa (>1% of total reads in NGS analysis), single Lactobacillus species were detected in 64.6% of samples from women with term deliveries and 87.5% of those from women with preterm deliveries. Interestingly, the microbiota of three (75%) of the four women in the miscarriage group were dominated by L. iners; that of the fourth (25%) woman was dominated by U. parvum (12.6%, based on read numbers). Using more than 785,508 Lactobacillus-specific pyrosequencing reads belonging to 42 species, we verified that Lactobacillus dominated the vaginal microbiota of pregnant women. More than 505,819 Lactobacillus-specific reads belonging to 37 species were detected in vaginal swabs from women who delivered at term. In contrast, only six Lactobacillus species were detected in pyrosequencing reads from women who had PTBs. The Lactobacillus species detected in women who delivered at term were primarily L. crispatus (45.5%) and L. iners (24.9%), followed by L. jensenii (4.8%). Furthermore, L. delbrueckii, L. acidophilus, L. psittaci, L. pontis, L. vaginalis, and L. helveticus were detected only in several women in the term delivery group. Non-Lactobacillus species (74.6%) were dominant in the vaginal swabs from women who had PTBs; A. vaginae (17.2%), Prevotella amnii (9.2%), Streptococcus agalactiae (9.1%), G. vaginalis (8.5%), Megasphaera sp. (8.2%), and Escherichia coli (2.6%) were most common. Most (6/8) vaginal microbiota profiles from the PTB group could not be classified as Lactobacillus dominant, and were assigned to the diverse CST IV. Considering both read numbers and the prevalence of vaginal microbes, 75% (6/8) and 62.5% (5/8) of vaginal swabs from the PTB group contained reads specific to G. vaginalis and A. vaginae, respectively. These results suggest that G. vaginalis and A. vaginae may serve as taxonomic biomarkers of high-risk pregnancy and the risk of PTB, consistent with previous reports [38, 39].
Overall, the microbiota profiles of pregnant women could not be distinguished from those of non-pregnant women. However, several differences were observed between the microbiota profiles of pregnant women with term deliveries and those of non-pregnant women. Pregnant women with term deliveries exhibited much greater relative abundances of Lactobacillus spp. (p value: 0.0341) compared with non-pregnant women (Fig. 1). The vaginal microbiota of pregnant women had less diversity, richness, and less abundance of U. parvum than did that of non-pregnant women, consistent with previous report [40]. However, the prevalence of U. parvum was not different between non-pregnant women (33.3%) and pregnant women with term deliveries (37.5%), which is not consistent with the previous report [41].
In the present study, L crispatus and L. iners were identified as dominant microbial species in the vaginal microbial flora of 126 Korean women. In addition, women with normal pregnancies exhibited less bacterial diversity and greater abundances of Lactobacillus species compared with non-pregnant women. These results are quite consistent with those of previous studies [40, 42]. In the vagina, Lactobacillus spp. generate a low-pH environment through lactic acid production, which inhibits vaginal pathogens. Despite the observed variation in the microbial composition of samples from women who experienced PTB, we detected clear decreases in populations of Lactobacillus spp. and concomitant increases in a diverse non-Lactobacillus bacterial flora. A. vaginae, Streptococcus sp., Prevotella sp., L. amnionii, Ureaplasma sp., and G. vaginalis were the main non-Lactobacillus species identified in samples from the PTB group. These bacterial species are presumed to be the causative vaginal microbes in vaginitis [43, 44]. Therefore, improvement of the vaginal environment with antibacterial and lactic acid–generating Lactobacillus spp., such as L. crispatus, may help to prevent PTB. In the PCoA, the cases of PTB (n = 8) and miscarriage (n = 4) clustered distinctly in the ordination space and therefore had similar vaginal microbial profiles (Fig. 3C). Based on these correlations, high-risk pregnancy outcomes, such as preterm delivery and miscarriage, may be predictable. In conclusion, we identified several differences in the vaginal microbiota profiles of native Korean pregnant and non-pregnant women. Less diversity, greater abundance of Lactobacillus, and less abundance but no difference of prevalence of U. parvum were observed in Korean pregnant women in the term delivery group. These findings represent an important step for exploitation of the diagnostic potential of microbiota profiles for the prediction of high-risk pregnancy in Korea, as well as for the development of alternative therapeutic treatments involving microbiological intervention.
Supplemental Materials
Supplementary data for this paper are available on-line only at http://jmb.or.kr.
Acknowledgement
This work was supported by the Korea Health Technology R&D Project (HI14C0368 & HI17C1238), Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2017R1A6A1A03015713) and partially supported by the Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program. All authors of the present paper declare that no-financial interest exists in relation to the work described.
Footnotes
Conflict of Interest
The authors have no financial conflicts of interest to declare.
REFERENCES
- 1.Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007;449:811–818. doi: 10.1038/nature06245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Seon-Kyun Kim, Robin B Guevarra, You-Tae Kim, Joongi Kwon, Hyeri Kim, Jae Hyoung Cho, et al. Role of probiotics in human gut microbiome-associated diseases. J. Microbiol. Biotechnol. 2019;29:1335–1340. doi: 10.4014/jmb.1906.06064. [DOI] [PubMed] [Google Scholar]
- 3.Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474:327–336. doi: 10.1038/nature10213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sungmi Choi, Yu-Jin Hwang, Min-Jeong Shin, Hana Yi. Difference in the gut microbiome between ovariectomyinduced obesity and diet-induced obesity. J. Microbiol. Biotechnol. 2017;27:2228–2236. doi: 10.4014/jmb.1710.10001. [DOI] [PubMed] [Google Scholar]
- 5.Onderdonk, AB, Delaney ML, Fichorova RN. The human microbiome during bacterial vaginosis. Clin. Microbiol. Rev. 2016;29:223–238. doi: 10.1128/CMR.00075-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ollberding NJ, Völgyi E, Macaluso M, Kumar R, Morrow C, Tylavsky FA, et al. Urinary microbiota associated with preterm birth: results from the conditions affecting neurocognitive development and learning in early childhood (CANDLE) study. PLoS One. 2016;11:e0162302. doi: 10.1371/journal.pone.0162302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR, Forney LJ. Characterization of vaginal microbial communities in adult healthy women using cultivationindependent methods. Microbiology. 2004;150:2565–2573. doi: 10.1099/mic.0.26905-0. [DOI] [PubMed] [Google Scholar]
- 8.DiGiulio DB, Callahan BJ, McMurdie PJ, Costello EK, Lyell DJ, Robaczewska A, et al. Temporal and spatial variation of the human microbiota during pregnancy. Proc. Natl. Acad. Sci. USA. 2015;112:11060–11065. doi: 10.1073/pnas.1502875112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Alioua S, Abdi A, Fhoula I, Bringel F, Boudabous A, Ouzari IH. Diversity of vaginal lactic acid bacterial microbiota in 15 algerian pregnant women with and without bacterial vaginosis by using culture independent method. J. Clin. Diagn. Res. 2016;10:DC23–DC27. doi: 10.7860/JCDR/2016/21621.8546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hammerschlag MR, Alpert S, Onderdonk AB, Thurston P, Drude E, McCormack WM, et al. Anaerobic microflora of the vagina in children. Am. J. Obstet. Gynecol. 1978;131:853–856. doi: 10.1016/S0002-9378(16)33130-1. [DOI] [PubMed] [Google Scholar]
- 11.Farage M, Maibach H. Lifetime changes in the vulva and vagina. Arch. Gynecol. Obstet. 2006;273:195–202. doi: 10.1007/s00404-005-0079-x. [DOI] [PubMed] [Google Scholar]
- 12.Gupta S, Kumar N, Singhal N, Kaur R, Manektala U. Vaginal microflora in postmenopausal women on hormone replacement therapy. Indian J. Pathol. Bacteriol. 2006;49:457–461. [PubMed] [Google Scholar]
- 13.Cone RA. Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV. J. Infect. Dis. 2014;210:S616–S621. doi: 10.1093/infdis/jiu459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hyman RW, Fukushima M, Jiang H, Fung E, Rand L, Johnson B, et al. Diversity of the vaginal microbiome correlates with preterm birth. Reprod. Sci. 2013;21:32–40. doi: 10.1177/1933719113488838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Petricevic L, Domig KJ, Nierscher FJ, Sandhofer MJ, Fidesser M, Krondorfer I, et al. Characterisation of the vaginal Lactobacillus microbiota associated with preterm delivery. Sci. Rep. 2014;4:5136. doi: 10.1038/srep05136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ. 1994;308:295–298. doi: 10.1136/bmj.308.6924.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Llahi-Camp JM, Rai R, Ison C, Regan L, Taylor-Robinson D. Association of bacterial vaginosis with a history of second trimester miscarriage. Hum. Reprod. 1996;11:1575–1578. doi: 10.1093/oxfordjournals.humrep.a019440. [DOI] [PubMed] [Google Scholar]
- 18.Martius J, Eschenbach DA. The role of bacterial vaginosis as a cause of amniotic fluid infection, chorioamnionitis and prematurity. Arch. Gynecol. Obstet. 1990;247:1–13. doi: 10.1007/BF02390649. [DOI] [PubMed] [Google Scholar]
- 19.Watts DH, Krohn MA, Hillier SL, Eschenbach DA. Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet. Gynecol. 1990;75:52–58. [PubMed] [Google Scholar]
- 20.Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Bieda J, et al. The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term. Microbiome. 2014;2:18. doi: 10.1186/2049-2618-2-18. doi: 10.1186/2049-2618-2-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Borgdorff H, van der Veer C, van Houdt R, A lberts C J, d e Vries HJ, Bruisten SM, et al. The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands. PLoS One. 2017;12:e0181135. doi: 10.1371/journal.pone.0181135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Haque MM, M erchant M, Kumar PN, D utta A, Mande SS. First-trimester vaginal microbiome diversity: a potential indicator of preterm delivery risk. Sci. Rep. 2017;7:16145. doi: 10.1038/s41598-017-16352-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Callahan BJ, DiGiulio DB, Goltsman DSA, Sun CL, Costello EK, Jeganathan P, et al. Replication and refinement of a vaginal microbial signature of preterm birth in two racially distinct cohorts of US women. Proc. Natl. Acad. Sci. USA. 2017;114:9966–9971. doi: 10.1073/pnas.1705899114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Chaban B, Links MG, Jayaprakash TP, Wagner EC, Bourque DK, Lohn Z, et al. Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle. Microbiome. 2014;2:23. doi: 10.1186/2049-2618-2-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chun J, Kim KY, Lee J-H, Choi Y. The analysis of oral microbial communities of wild-type and toll-like receptor 2deficient mice using a 454 GS FLX Titanium pyrosequencer. BMC Microbiol. 2010;10:101. doi: 10.1186/1471-2180-10-101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Hur M, Kim Y, Song HR, Kim JM, Choi YI, Yi H. Effect of genetically modified Poplars on soil microbial communities during the phytoremediation of waste mine tailings. Appl. Environ. Microbiol. 2011;77:7611–7619. doi: 10.1128/AEM.06102-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kim BS, Kim JN, Yoon SH, Chun J, Cerniglia CE. Impact of enrofloxacin on the human intestinal microbiota revealed by comparative molecular analysis. Anaerobe. 2012;18:310–320. doi: 10.1016/j.anaerobe.2012.01.003. [DOI] [PubMed] [Google Scholar]
- 28.Huber T, Faulkner G, Hugenholtz P. Bellerophon: a program to detect chimeric sequences in multiple sequence alignments. Bioinformatics. 2004;20:2317–2319. doi: 10.1093/bioinformatics/bth226. [DOI] [PubMed] [Google Scholar]
- 29.Kim OS, Cho YJ, Lee K, Yoon SH, Kim M, Na H, et al. Introducing Eztaxon-e: a prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int. J. Syst. Evol. Microbiol. 2012;62:716–721. doi: 10.1099/ijs.0.038075-0. [DOI] [PubMed] [Google Scholar]
- 30.Hamady M, Lozupone C, Knight R. Fast UniFrac:facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data. ISME J. 2010;4:17–27. doi: 10.1038/ismej.2009.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods. 2010;7:335–336. doi: 10.1038/nmeth.f.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Caporaso JG, Bittinger K, Bushman FD, DeSantis TZ, Andersen GL, Knight R. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics. 2010;26:266–267. doi: 10.1093/bioinformatics/btp636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A, et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn. Ther. 2012;31:141–146. doi: 10.1159/000336662. [DOI] [PubMed] [Google Scholar]
- 34.Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA. 2011;108:4680–4687. doi: 10.1073/pnas.1002611107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Redelinghuys MJ, Ehlers MM, D reyer AW, L ombaard H A, Kock MM. Comparison of the new Mycofast Revolution assay with a molecular assay for the detection of genital mycoplasmas from clinical specimens. BMC Infect. Dis. 2013;13:453. doi: 10.1186/1471-2334-13-453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kwak DW, Hwang HS, Kwon JY, Park YW, Kim YH. Co-infection with vaginal Ureaplasma urealyticum and Mycoplasma hominis increases adverse pregnancy outcomes in patients with preterm labor or preterm premature rupture of membranes. J. Matern. Fetal Neonatal Med. 2014;27:333–337. doi: 10.3109/14767058.2013.818124. [DOI] [PubMed] [Google Scholar]
- 37.Cox C, Saxena N, Watt AP, Gannon C, McKenna JP, Fairley DJ, et al. The common vaginal commensal bacterium Ureaplasma parvum is associated with chorioamnionitis in extreme preterm labor. J. Matern. Fetal Neonatal Med. 2016;29:3646–3651. doi: 10.3109/14767058.2016.1140734. [DOI] [PubMed] [Google Scholar]
- 38.Tabatabaei N, Eren AM, Barreiro LB, Yotova V, Dumaine A, Allard C, Fraser WD. Vaginal microbiome in early pregnancy and subsequent risk of spontaneous preterm birth: a case-control study. BJOG. 2018;126:349–358. doi: 10.1111/1471-0528.15299. [DOI] [PubMed] [Google Scholar]
- 39.Bretelle F, Rozenberg P, Pascal A, Favre R, Bohec C, Loundou A, et al. High Atopobium vaginae and Gardnerella vaginalis vaginal loads are associated with preterm birth. Clin. Infect. Dis. 2015;60:860–867. doi: 10.1093/cid/ciu966. [DOI] [PubMed] [Google Scholar]
- 40.Freitas AC, Bocking A, Hill JE, Money DM; VOGUE Research Group. Increased richness and diversity of the vaginal microbiota and spontaneous preterm birth. Microbiome. 2018;6:117. doi: 10.1186/s40168-018-0502-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Freitas AC, Chaban B, Bocking A, Rocco M, Yang S, Hill JE, et al. The vaginal microbiome of pregnant women is less rich and diverse, with lower prevalence of Mollicutes, compared to non-pregnant women. Sci. Rep. 2017;7:9212. doi: 10.1038/s41598-017-07790-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Lee JE, Lee S, Lee H, Song YM, Lee K, Han MJ, et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One. 2013;8:e63514. doi: 10.1371/journal.pone.0063514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Onderdonk AB, Delaney ML, Fichorova RN. The human microbiome during bacterial vaginosis. Clin. Microbiol. Rev. 2016;29:223–238. doi: 10.1128/CMR.00075-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Vitali B, Cruciani F, Picone G, Parolin C, Donders G, Laghi L. Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis. Eur. J. Clin. Microbiol. Infect. Dis. 2015;34:2367–2376. doi: 10.1007/s10096-015-2490-y. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Raw sequence data files for the 126 samples described in this study are available in the European Nucleotide Archive under study accession PRJEB33541. Due to ethical and legal restrictions related to protecting participant privacy imposed by Konyang Medical School IRB, all other relevant data are available upon request pending ethical approval.